Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Enterprise Value: 2020-2024

Historic Enterprise Value for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to -$49.7 million.

  • Oncology Institute's Enterprise Value rose 4165.23% to -$27.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$27.7 million, marking a year-over-year increase of 4165.23%. This contributed to the annual value of -$49.7 million for FY2024, which is 4005.31% up from last year.
  • Latest data reveals that Oncology Institute reported Enterprise Value of -$49.7 million as of FY2024, which was up 4005.31% from -$82.9 million recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Enterprise Value peaked at -$6.0 million during FY2020, and registered a low of -$115.2 million during FY2021.
  • Over the past 5 years, Oncology Institute's median Enterprise Value value was -$73.8 million (recorded in 2022), while the average stood at -$65.5 million.
  • In the last 5 years, Oncology Institute's Enterprise Value crashed by 182020.67% in 2021 and then skyrocketed by 4005.31% in 2024.
  • Oncology Institute's Enterprise Value (Annual) stood at -$6.0 million in 2020, then crashed by 1820.21% to -$115.2 million in 2021, then skyrocketed by 35.92% to -$73.8 million in 2022, then decreased by 12.26% to -$82.9 million in 2023, then skyrocketed by 40.05% to -$49.7 million in 2024.
  • Its Enterprise Value was -$49.7 million in FY2024, compared to -$82.9 million in FY2023 and -$73.8 million in FY2022.